206 related articles for article (PubMed ID: 36276109)
1. The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database.
Wu Z; Qiu X; Zhi Y; Shi X; Lv G
Front Oncol; 2022; 12():993524. PubMed ID: 36276109
[TBL] [Abstract][Full Text] [Related]
2. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
Chen J; Yang Y; Liu Y; Kan H
World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy combined with radiotherapy can benefit more unresectable HCC patients with portal and/or hepatic vein invasion: a retrospective analysis of the SEER database.
Qiu X; Cai J; Chen H; Yao J; Xiao C; Li R; Xiao J; Zhang J; Sui X; Lu T; Zheng J; Zhang Y; Yang Y
Front Oncol; 2023; 13():1098686. PubMed ID: 37409255
[TBL] [Abstract][Full Text] [Related]
4. Can Elderly Patients With Pancreatic Cancer Gain Survival Advantages Through More Radical Surgeries? A SEER-Based Analysis.
Xie D; Qian B; Yang J; Peng X; Li Y; Hu T; Lu S; Chen X; Han Y
Front Oncol; 2020; 10():598048. PubMed ID: 33194764
[TBL] [Abstract][Full Text] [Related]
5. Impact of Surgery on Non-Functional Pancreatic Neuroendocrine Tumors ≤2 cm: Analyses With Propensity Score-Based Inverse Probability of Treatment Weighting.
Ye J; Wu H; Li J; Liu C
Front Surg; 2022; 9():890564. PubMed ID: 36071950
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of total
Yang Z; Tao Q; Mijiti S; Luo D; Tang X; Liu J; Jiang L; Liu Z; Liang C; Tu X; Zhao P; Luu AM; Serra F; Gelmini R; Wang Y; Zheng Y
Ann Transl Med; 2022 May; 10(10):539. PubMed ID: 35722386
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.
Li G; Tian ML; Bing YT; Tao LY; Wang HY; Jiang B; Yuan CH; Xiu DR
Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors of Lymph Node Metastasis in Patients with Pancreatic Neuroendocrine Tumors (PNETs).
Wang Z; Cao F; Zhang Y; Fang Y; Li F
Gastroenterol Res Pract; 2020; 2020():1946156. PubMed ID: 33061957
[TBL] [Abstract][Full Text] [Related]
9. Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.
Sun Y; Wang Y; Li R; Kang G; Zhang M; Chen X; Jin M; Liu Y; He Y; Zhu X; Kang Q; Zhou F; Yu Q
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101432. PubMed ID: 32386797
[TBL] [Abstract][Full Text] [Related]
10. A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment.
Wang B; Chen LJ; Wang XY
Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587
[TBL] [Abstract][Full Text] [Related]
11. The impact of surgery in metastatic pancreatic neuroendocrine tumors: a competing risk analysis.
He CB; Zhang Y; Cai ZY; Lin XJ
Endocr Connect; 2019 Mar; 8(3):239-251. PubMed ID: 30726772
[TBL] [Abstract][Full Text] [Related]
12. Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database.
Zou L; Guo T; Ye L; Zhou Y; Chu L; Chu X; Ni J; Zhu Z; Yang X
Front Oncol; 2020; 10():572462. PubMed ID: 33324549
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in gastric cancer with multi-organ metastases.
Wang T; Liu C; Wang W; Huang B; Yu R; Huang M; Dong W
Transl Cancer Res; 2022 Jun; 11(6):1534-1551. PubMed ID: 35836507
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Nomogram Based on the Metastatic Lymph Node Ratio for T
Shi J; Liu S; Cao J; Shan S; Ren C; Zhang J; Wang Y
Front Oncol; 2022; 12():899759. PubMed ID: 35574346
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study.
Chen WK; Wu ZG; Xiao YB; Wang QQ; Yu DD; Cai J; Zhou CF
Technol Cancer Res Treat; 2021; 20():15330338211004914. PubMed ID: 33929915
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma.
Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z
J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035
[TBL] [Abstract][Full Text] [Related]
17. Second primary cancers and survival among neuroendocrine tumor patients.
Bateni SB; Coburn NG; Law C; Singh S; Myrehaug S; Assal A; Hallet J
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37184947
[TBL] [Abstract][Full Text] [Related]
18. Survival Benefit of Primary Tumor Resection Among Elderly Patients with Pancreatic Neuroendocrine Tumors.
Toyoda J; Sahara K; Tsilimigras DI; Miyake K; Yabushita Y; Homma Y; Kumamoto T; Matsuyama R; Pawlik TM
World J Surg; 2021 Dec; 45(12):3643-3651. PubMed ID: 34379172
[TBL] [Abstract][Full Text] [Related]
19. Partial penectomy or total penectomy for T1 and T2 squamous cell carcinoma of the penis?
Zheng QL; Wu YP; Zhang ZP; Xu N
Transl Cancer Res; 2019 Sep; 8(5):1750-1755. PubMed ID: 35116925
[TBL] [Abstract][Full Text] [Related]
20. Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis.
Sonbol MB; Mazza GL; Mi L; Oliver T; Starr J; Gudmundsdottir H; Cleary SP; Hobday T; Halfdanarson TR
Oncologist; 2022 Jul; 27(7):573-578. PubMed ID: 35348774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
